IDENTIFY NEW FUNDING

    Opportunities

    Oncology Drug Funding

    2013

    This Report is only Available on request...​

    RELEASED - April 2013

    Download Flyer1.1 MB
    Download TOC1.2 MB
    Free Download Reuest

    321

    Oncology Focused Investors

    Oncology Drug Funding 2013 is first of its kind funding intelligence report, which provides complete landscape on cancer drug funding starting from early, mid to late stage funding and offers quick navigation on past 10 years major investments in the domain.

    First Report to Cover all Aspects of Cancer Drug Funding Intelligence

    largest coverage

    providing intelligence at fingertips

    1
    Investors

    Active Venture Capital Firm Profiles

    1
    Companies

    Oncology Company Funding Details

    1
    Venture Partners

    Venture Partners Professional Details

    1 +
    Funding Round Covered

    Funding Round / Series Details